Updates are available Erratum dated 2022-07-04
Click to view Erratum: https://doi.org/10.1007/s12275-022-1682-2
-
Authors
Han, Hye Sung
Shin, Sun Hye
Choi, Bo-Yun
Koo, Nayeon
Lim, Sanghyun
Son, Dooheon
Chung, Myung Jun
Park, Kui Young
Sul, Woo Jun
- License Information
-
More Information
Article History
Received: 6 October 2021
Revised: 13 January 2022
Accepted: 19 January 2022
First Online: 14 March 2022
Change Date: 4 July 2022
Change Type: Erratum
Change Details: An Erratum to this paper has been published:
Change Details: https://doi.org/10.1007/s12275-022-1682-2
Ethics
: <b>Conflict of Interest</b> Sanghyun Lim, Dooheon Son, and Myung Jun Chung are principal researcher, researcher, and CEO respectively at Cell Biotech, Co., Ltd.
: <b>Ethical Statements</b> This double-blind, randomized, placebo-controlled, split-face study was approved by the Institutional Review Board of Chung-Ang University Hospital (Approval No. 1962-005-376). The study was conducted in accordance with the principles of the Declaration of Helsinki.
